1HHZ image
Deposition Date 2000-12-29
Release Date 2003-09-05
Last Version Date 2025-04-09
Entry Detail
PDB ID:
1HHZ
Title:
Deglucobalhimycin in complex with cell wall pentapeptide
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
0.99 Å
R-Value Free:
0.14
R-Value Observed:
0.10
Space Group:
P 32 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:DEGLUCOBALHIMYCIN
Chain IDs:A, B, C
Chain Length:7
Number of Molecules:3
Biological Source:AMYCOLATOPSIS SP.
Polymer Type:polypeptide(L)
Molecule:CELL WALL PEPTIDE
Chain IDs:D, E, F
Chain Length:5
Number of Molecules:3
Biological Source:synthetic construct
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
OMY A TYR ?
Peptide-like Molecules
PRD_000485
Primary Citation
Structures of Glycopeptide Antibiotics with Peptides that Model Bacterial Cell-Wall Precursors
J.Mol.Biol. 318 723 ? (2002)
PMID: 12054818 DOI: 10.1016/S0022-2836(02)00146-8

Abstact

The vancomycin-related antibiotics balhimycin and degluco-balhimycin have been crystallized in complexes with di-, tri- and pentapeptides that emulate bacterial cell-wall precursors, and four structures determined at atomic resolution (<1 A). In addition to the features expected from previous structural and spectroscopic studies, two new motifs were observed that may prove important in the design of antibiotics modified to overcome bacterial resistance. A changed binding mode was found in two dipeptide complexes, and a new type of face-to-face oligomerization (in addition to the well-established back-to-back dimerization) was seen when the model peptide reaches a critical fraction of the size of the cell-wall precursor pentapeptide. The extensive interactions involving both antibiotic and peptide molecules in this interface should appreciably enhance the kinetic and thermodynamic stability of the complexes. In the pentapeptide complex, the relative positions of the peptides are close to those required for d-Ala elimination, so this structure may provide a realistic model for the prevention of the enzyme-catalyzed cell-wall crosslinking by antibiotic binding.

Legend

Protein

Chemical

Disease

Primary Citation of related structures